CS
BMY icon

Capital Square’s Bristol-Myers Squibb BMY Stock Holding History

Capital Square’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
5,085
+35
+0.7% +$2.01K 0.13% 173
2026
Q1 		$297K Buy
5,050
+38
+0.8% +$2.21K 0.14% 158
2025
Q4 		$270K Sell
5,012
-991
-17% -$47.7K 0.14% 159
2025
Q3 		$271K Buy
6,003
+59
+1% +$2.75K 0.14% 154
2025
Q2 		$279K Buy
5,944
+50
+0.8% +$2.45K 0.15% 152
2025
Q1 		$359K Buy
5,894
+44
+0.8% +$2.56K 0.21% 111
2024
Q4 		$349K Buy
5,850
+8
+0.1% +$447 0.2% 121
2024
Q3 		$302K Buy
5,842
+49
+0.8% +$2.3K 0.18% 120
2024
Q2 		$247K Sell
5,793
-462
-7% -$20.7K 0.16% 128
2024
Q1 		$339K Buy
6,255
+79
+1% +$4.02K 0.24% 102
2023
Q4 		$317K Sell
6,176
-134
-2% -$7.03K 0.36% 74
2023
Q3 		$359K Buy
6,310
+92
+1% +$5.64K 0.48% 58
2023
Q2 		$398K Buy
6,218
+44
+0.7% +$2.95K 0.37% 78
2023
Q1 		$437K Buy
6,174
+274
+5% +$19.3K 0.4% 70
2022
Q4 		$425K Sell
5,900
-138
-2% -$10.4K 0.38% 76
2022
Q3 		$429K Buy
6,038
+212
+4% +$15.4K 0.39% 71
2022
Q2 		$448K Sell
5,826
-176
-3% -$13.4K 0.37% 75
2022
Q1 		$438K Sell
6,002
-138
-2% -$9.27K 0.31% 90
2021
Q4 		$381K Buy
6,140
+49
+0.8% +$2.87K 0.26% 99
2021
Q3 		$362K Buy
6,091
+735
+14% +$48.4K 0.26% 104
2021
Q2 		$359K Buy
5,356
+106
+2% +$6.91K 0.26% 103
2021
Q1 		$328K Buy
5,250
+1,167
+29% +$72.6K 0.24% 115
2020
Q4 		$253K Sell
4,083
-453
-10% -$27.9K 0.21% 123
2020
Q3 		$273K Sell
4,536
-46
-1% -$2.77K 0.28% 104
2020
Q2 		$269K Sell
4,582
-96
-2% -$5.74K 0.29% 107
2020
Q1 		$261K Buy
4,678
+79
+2% +$4.83K 0.3% 93
2019
Q4 		$295K Buy
+4,599
New +$263K 0.28% 96

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Square's BMY Position: Q2 2026 in Review

Capital Square increased its Bristol-Myers Squibb (BMY) stake by 0.69% in Q2 2026, buying an estimated $2.01K and bringing the position to 5,085 shares worth $293K. The position accounts for 0.13% of the portfolio, ranked #173.

Capital Square first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $448K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Capital Square held 5,085 shares of Bristol-Myers Squibb worth $293K as of Q2 2026.
  • Capital Square bought 35 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.01K.
  • Bristol-Myers Squibb made up 0.13% of Capital Square's portfolio in Q2 2026, its #173 holding.
  • Capital Square first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Capital Square's Bristol-Myers Squibb position peaked at $448K in Q2 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Capital Square's 13F filing for Q2 2026, filed 13 Aug 2026.